Claude Nicaise's Net Worth
$2.06 Million
Who is Claude Nicaise?
Claude Nicaise has an estimated net worth of $2.06 Million. This is based on reported shares across multiple companies, which include Sarepta Therapeutics, Inc., Gain Therapeutics, Inc., Chemomab Therapeutics Ltd., and CASSAVA SCIENCES INC.
SEC CIK
Claude Nicaise's CIK is 0001644162
Past Insider Trading and Trends
2023 was Claude Nicaise's most active year for acquiring shares with 7 total transactions. Claude Nicaise's most active month to acquire stocks was the month of February. 2023 saw Claude Nicaise paying a total of $0.00 for 60,841 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sarepta Therapeutics, Inc. (SRPT) Snapshot price: $126.14
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +11.31% | 1.85K |
—
|
—
| 18.17K |
Mar 1
| |||
Form 4
| +10.29% | 1.52K |
—
|
—
| 16.33K |
Mar 6
| |||
Form 4
| +24.92% | 2.95K |
—
|
—
| 14.8K |
Mar 7
| |||
Form 4
| +29.87% | 2.73K |
—
|
—
| 11.85K |
Mar 3
| |||
Form 4
| +29.43% | 2.08K |
—
|
—
| 9.13K |
Feb 28
| |||
Form 4
| +30.14% | 1.63K |
—
|
—
| 7.05K |
Mar 4
| |||
Form 4
| +170.90% | 3.42K |
—
|
—
| 5.42K |
Mar 5
| |||
Form 4
| +100.00% | 1K |
—
|
—
| 2K |
Mar 10
| |||
Form 4
|
∞
| 1K |
—
|
—
| 1K |
Feb 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Gain Therapeutics, Inc. (GANX) Snapshot price: $4.64
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Chemomab Therapeutics Ltd. (CMMB) Snapshot price: $0.59
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 19 - Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CASSAVA SCIENCES INC (SAVA) Snapshot price: $25.42
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||